CymitQuimica logo

CAS 154947-66-7

:

LL-37

Beschreibung:
LL-37 ist ein menschliches kathelicidin-antimikrobielles Peptid (CAMP), das eine entscheidende Rolle in der angeborenen Immunantwort spielt. Es besteht aus 37 Aminosäuren und ist bekannt für seine breit gefächerte antimikrobielle Aktivität gegen verschiedene Erreger, einschließlich Bakterien, Pilzen und Viren. LL-37 weist eine einzigartige amphipathische Struktur auf, die es ihm ermöglicht, mit mikrobiellen Membranen zu interagieren und diese zu destabilisieren, was zur Zelllyse führt. Darüber hinaus besitzt es immunmodulatorische Eigenschaften, die Entzündungen und Wundheilungsprozesse beeinflussen. LL-37 wird von verschiedenen Zellen produziert, einschließlich Neutrophilen und Epithelzellen, und ist in verschiedenen Geweben zu finden, insbesondere während Infektionen oder Verletzungen. Seine Fähigkeit, Angiogenese zu fördern und Immunantworten zu modulieren, macht es zu einem interessanten Thema in der therapeutischen Forschung, insbesondere im Kontext von chronischen Wunden und Infektionen. Insgesamt ist LL-37 ein wesentlicher Bestandteil des Abwehrsystems des Wirts, der zur Aufrechterhaltung der Integrität von Haut und Schleimhäuten beiträgt.
Synonyme:
  • H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH
  • antibacterial protein LL-37 amide
  • LL-37(human)
Sortieren nach

Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte.
  • LL-37

    CAS:
    LL-37 is an antimicrobial peptide with angiogenic activity. It corresponds to the C-terminal sequence (134-170) of the human cathelicidin antimicrobial protein hCAP18/LL-37 and is extracellularly released from hCAP18/LL-37 by proteolytic processing. hCAP18/LL-37 is an effector of the innate immune system and is expressed in leukocytes and epithelial cells where it is upregulated in association with inflammation and injury. An overexpression of hCAP18/LL-37 in a series of breast carcinomas could be demonstrated. LL-37 has been suggested to stimulate epithelial cell proliferation partially through formyl peptide receptor-like 1 (FPRL1) since blocking the receptor with pertussis toxin decreased the proliferative effect of LL-37 by approximately 50 %.
    Formel:C205H340N60O53
    Reinheit:96.7%
    Farbe und Form:White
    Molekulargewicht:4493.33

    Ref: 01-4042456

    1mg
    340,00€
    5mg
    992,00€
  • LL-37

    CAS:
    Formel:C207H341F3N60O55
    Reinheit:98%
    Molekulargewicht:4607.2866

    Ref: IN-DA00ATB8

    1mg
    158,00€
    5mg
    341,00€
    10mg
    694,00€
    25mg
    Nachfragen
    50mg
    Nachfragen
  • LL-37, Human

    CAS:
    LL-37, Human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity.
    Formel:C205H340N60O53
    Reinheit:98%
    Farbe und Form:Solid
    Molekulargewicht:4493.26
  • LL-37 ( Human)

    CAS:
    <p>LL-37 is a 37 amino acid peptide that is produced by neutrophils and other leukocytes. This peptide has been shown to have anti-inflammatory properties, which may be due to its ability to bind and activate the G protein coupled receptor (GPCR) formyl peptide receptor-like 1 (FPRL1), leading to inhibition of the production of inflammatory mediators such as IL-8. LL-37 also binds to ion channels, which may lead to membrane depolarization, thereby blocking calcium influx into the cell. LL-37 has been shown to inhibit the activation of T cells by inhibiting T cell receptor signaling and reducing cytokine production.<br>LL-37 also has a high affinity for antibody binding sites on B cells and macrophages and can bind with high specificity to IgE on mast cells, leading to inhibition of mast cell degranulation. The binding of LL-37 with these receptors leads to reduced inflammation in tissues, which may</p>
    Formel:C205H340N60O53
    Reinheit:Min. 95%
    Molekulargewicht:4,493.3 g/mol

    Ref: 3D-PLL-4445-S

    100µg
    465,00€
  • Cathelicidin LL 37

    CAS:
    <p>LL-37 is a potent antimicrobial peptide that has been shown to be effective against cancer cells and is currently being investigated as a potential antineoplastic agent. LL-37 binds to the leukocyte receptor, which leads to chemotaxis, increased expression of p53 and apoptosis. LL-37 also induces apoptotic cell death in epithelial tissues, both in vitro and in vivo. This peptide has been shown to induce death in cancer cells, as well as cell death in other types of cells.</p>
    Formel:C205H340N60O53
    Reinheit:Min. 95%
    Molekulargewicht:4,493.27 g/mol

    Ref: 3D-FL110043

    1mg
    336,00€
    2mg
    502,00€
    5mg
    962,00€
    10mg
    1.600,00€
    500µg
    200,00€